How important is bleomycin in the adriamycin plus bleomycin plus vinblastine plus dacarbazine regimen?

被引：37

作者：

Canellos, GP ^{[1
]}

Duggan, D

Johnson, J

Niedzwiecki, D

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] SUNY Syracuse, Syracuse, NY 13210 USA

[3] Duke Univ, Durham, NC USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 08期

关键词：

D O I：

10.1200/JCO.2004.99.010

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1532 / 1533

页数：2

共 3 条

[1] CHEMOTHERAPY OF ADVANCED HODGKINS-DISEASE WITH MOPP, ABVD, OR MOPP ALTERNATING WITH ABVD [J].

CANELLOS, GP ;

ANDERSON, JR ;

PROPERT, KJ ;

NISSEN, N ;

COOPER, MR ;

HENDERSON, ES ;

GREEN, MR ;

GOTTLIEB, A ;

PETERSON, BA .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) :1478-1484

[2] Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: Report of an intergroup trial [J].

Duggan, DB ;

Petroni, GR ;

Johnson, JL ;

Glick, JH ;

Fisher, RI ;

Connors, JM ;

Canellos, GP ;

Peterson, BA .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (04) :607-614

[3] EFFECT OF TREATMENT FOR HODGKINS-DISEASE ON PULMONARY-FUNCTION - RESULTS OF A PROSPECTIVE-STUDY [J].

HORNING, SJ ;

ADHIKARI, A ;

RIZK, N ;

HOPPE, RT ;

OLSHEN, RA .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (02) :297-305

← 1 →